Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.1M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
6.16M
-
Shares change
-
-138K
-
Total reported value, excl. options
-
$48.1M
-
Value change
-
-$164K
-
Put/Call ratio
-
0.51
-
Number of buys
-
42
-
Number of sells
-
-29
-
Price
-
$7.81
Significant Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q1 2025
96 filings reported holding INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.16M shares
of 27.1M outstanding shares and own 22.74% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (948K shares), Praetorian PR LLC (865K shares), VANGUARD GROUP INC (827K shares), RAYMOND JAMES FINANCIAL INC (382K shares), GEODE CAPITAL MANAGEMENT, LLC (365K shares), MILLENNIUM MANAGEMENT LLC (241K shares), STATE STREET CORP (236K shares), GatePass Capital, LLC (235K shares), Rhenman & Partners Asset Management AB (178K shares), and NORTHERN TRUST CORP (152K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.